Immune-related adverse kidney events by immune checkpoint inhibitors; a narrative review on current studies
Chemotherapy-associated renal injury is considered one of the major concerns among nephrological and oncological practice. The use of novel anti-neoplastic therapies that target carcinomas has helped in the detection of this form of renal injury. Immune checkpoint inhibitors (ICPIs) are a group of m...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2021-05-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | https://jnephropharmacology.com/PDF/npj-10416 |